RESPIRI CREATE TECHNOLOGY TO OPTIMISE HOW ASTHMA PATIENTS AND THEIR PHYSICIANS MONITOR AND MANAGE THEIR CONDITION

Asthma is a growing public health problem with over 340 million people diagnosed with asthma worldwide1.

Australia has one of the highest prevalence rates of asthma in the world with 2.7 million (1 in 9) Australians affected2.

In 2019, 11.2% of Australians have asthma3

Indigenous Australians are nearly twice as likely (1.9x) to report having asthma compared with non-indigenous Australians3

Asthma affects quality of life, productivity at work and school, and can lead to devastating outcomes such as death.  In 2017, 441 Australians died as a result of their asthma3.

Asthma places a significant economic burden on countries, with a cost of greater than $28 billion in Australia alone4.

ASTHMA CANNOT BE CURED BUT WITH APPROPRIATE MANAGEMENT, IT CAN BE CONTROLLED5

Healthcare authorities agree that supported asthma self-management improves asthma control, reduces hospital admissions and improves quality of life6.

Persons % by State/Territory

Asthma in Australia. Asthma Australia.  https://asthma.org.au/about-asthma/understanding-asthma/statistics/